LAWRENCE A. KENYON - 26 Sep 2024 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Chief Financial Officer, Director
Signature
/s/ Lawrence Kenyon
Issuer symbol
OTLK
Transactions as of
26 Sep 2024
Net transactions value
+$28,446
Form type
4
Filing time
30 Sep 2024, 16:53:23 UTC
Previous filing
22 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLK Common Stock Purchase $28,446 +5,000 +529% $5.69 5,946 26 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the Issuer's 1-for-20 reverse stock split effected on March 13, 2024.